UM Today UM Today University of Manitoba UM Today UM Today UM Today

Nature, Science, CTV: Vaginal microbes thwart HIV prevention

June 13, 2017 — 

As reported in Nature and Science:

Vaginal application of anti-retroviral drugs, such as tenofovir, before sex has had mixed results in preventing HIV infection in women. 

To learn why, Nichole Klatt at the University of Washington in Seattle, Adam Burgener at the Public Health Agency of Canada in Winnipeg, and their colleagues compared the vaginal bacterial communities of 688 South African women. The women had either mainly Lactobacillus species or a diverse population dominated by Gardnerella vaginalis, which is associated with bacterial vaginosis. The team then tracked whether the women contracted HIV over a 2.5-year period when they were given either tenofovir gel or a placebo. Tenofovir reduced the likelihood that women with mainly Lactobacilllus communities would get HIV, but the drug was less likely to protect women with a higher proportion of G. vaginalis and other similar microbes, which  metabolize tenofovir before the body’s cells can absorb it.

Screening women to identify the composition of their vaginal bacterial community before anti-retroviral treatment could help to improve HIV prevention, the authors suggest.

Read about it on CTV 

Research at the University of Manitoba is partially supported by funding from the Government of Canada Research Support Fund.


© University of Manitoba • Winnipeg, Manitoba • Canada • R3T 2N2

Emergency: 204-474-9341